Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Author(s): Allen Loyd V Jr
Issue: Sep/Oct 2015 - Volume 19, Number 5
View All Articles in Issue
Abstract: This is part 1 of a 2-part article on the topic of Nominations of Difficult to Compound Drugs to the FDA-PCAC. Part 2, which will discuss the evaluation procedure for determining which drugs are demonstrably difficult to compound, will be published in the International Journal of Pharmaceutical Compounding’s November-December 2015 issue.
Related Keywords: Loyd V. Allen, Jr., PhD, RPh, Drug Quality and Security Act, difficult to compound drugs, U.S. Food and Drug Administration, FDA, Pharmacy Compounding Advisory Committee
Related Categories: LEGAL, SUPPORT
Download in electronic PDF format for $35